Altaris Completes Investment in Solesis

May 28, 2021

Cleary Gottlieb represented Altaris Capital Partners (Altaris) in its acquisition of a 51% stake in Solesis Inc. (Solesis) from Compagnie Générale des Établissements Michelin SCA (Michelin), which is maintaining a 49% stake in Solesis.

The transaction terms have not been publicly disclosed. The transaction closed on May 28, 2021.

Altaris is an investment firm focused exclusively on the healthcare industry. Altaris targets companies that deliver value to the healthcare system by improving patient outcomes, eliminating unnecessary costs, increasing efficiency, and aligning stakeholder incentives.

Solesis is a life science and medical technology company that operates through its subsidiaries, The Secant Group LLC, SanaVita Medical LLC, and Charter Medical LLC. Solesis’ differentiated biomaterials enable customers to deliver advancements in life-saving therapies, with a specific focus on medical device technologies and biopharmaceuticals. Through a wide range of value-added tools and services, Solesis works closely with customers to facilitate innovation by leveraging next generation biomaterials.